|
Aug. 22, 2023 |
Aug. 21, 2023 |
B
Purchase
|
Kandera Reinhard
Chief Financial Officer
Executive Director
|
7,000
+19.4%
0.73
5,075
USD
|
7,000
+19.4%
|
0.73
|
5,075
USD
|
|
|
Aug. 17, 2023 |
Aug. 16, 2023 |
B
Purchase
|
Kandera Reinhard
Chief Financial Officer
Executive Director
|
8,000
+28.5%
0.71
5,712
USD
|
8,000
+28.5%
|
0.71
|
5,712
USD
|
|
|
July 11, 2023 |
July 11, 2023 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+7.5%
0.83
4,142
USD
|
5,000
+7.5%
|
0.83
|
4,142
USD
|
|
|
July 11, 2023 |
July 7, 2023 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+8.1%
0.81
4,050
USD
|
5,000
+8.1%
|
0.81
|
4,050
USD
|
|
|
July 7, 2023 |
July 5, 2023 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+8.8%
0.89
4,450
USD
|
5,000
+8.8%
|
0.89
|
4,450
USD
|
|
|
July 5, 2023 |
July 3, 2023 |
B
Purchase
|
Aldag Jorn
Chief Executive Officer
Executive Director
|
5,000
+9.6%
0.89
4,456
USD
|
5,000
+9.6%
|
0.89
|
4,456
USD
|
|
|
July 3, 2023 |
June 30, 2023 |
B
Purchase
|
Kandera Reinhard
Chief Financial Officer
Executive Director
|
12,000
+74.6%
0.88
10,560
USD
|
12,000
+74.6%
|
0.88
|
10,560
USD
|
|
|
Jan. 12, 2022 |
Dec. 21, 2021 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
2,205
-2.5%
2.49
5,490
USD
|
2,205
-2.5%
|
2.49
|
5,490
USD
|
|
|
Jan. 12, 2022 |
Dec. 21, 2021 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
7,440
-8.1%
2.49
18,526
USD
|
7,440
-8.1%
|
2.49
|
18,526
USD
|
|
|
Jan. 12, 2022 |
Dec. 21, 2021 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
5,304
-6.2%
2.49
13,207
USD
|
5,304
-6.2%
|
2.49
|
13,207
USD
|
|
|
April 23, 2021 |
April 21, 2021 |
S
Sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
328,620
-9.4%
11.60
3,812,386
USD
|
328,620
-9.4%
|
11.60
|
3,812,386
USD
|
|
|
March 29, 2021 |
March 25, 2021 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
28,546
-0.8%
13.12
374,569
USD
|
28,546
-0.8%
|
13.12
|
374,569
USD
|
|
|
March 26, 2021 |
March 24, 2021 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
52,690
-1.4%
13.70
721,616
USD
|
52,690
-1.4%
|
13.70
|
721,616
USD
|
|
|
March 25, 2021 |
March 23, 2021 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
40,000
-1.1%
13.91
556,476
USD
|
40,000
-1.1%
|
13.91
|
556,476
USD
|
|
|
March 24, 2021 |
March 22, 2021 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
40,534
-1.1%
14.54
589,263
USD
|
40,534
-1.1%
|
14.54
|
589,263
USD
|
|
|
March 23, 2021 |
March 19, 2021 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
166,230
-4.3%
14.60
2,427,739
USD
|
166,230
-4.3%
|
14.60
|
2,427,739
USD
|
|
|
Dec. 18, 2020 |
Dec. 17, 2020 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
16,478
-17.6%
11.76
193,781
USD
|
16,478
-17.6%
|
11.76
|
193,781
USD
|
|
|
Dec. 18, 2020 |
Dec. 17, 2020 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
11,501
-15.2%
11.70
134,562
USD
|
11,501
-15.2%
|
11.70
|
134,562
USD
|
|
|
Dec. 18, 2020 |
Dec. 16, 2020 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
380
-0.7%
11.70
4,446
USD
|
380
-0.7%
|
11.70
|
4,446
USD
|
|
|
Oct. 6, 2020 |
Oct. 2, 2020 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
300
-0.0%
10.00
3,000
USD
|
300
-0.0%
|
10.00
|
3,000
USD
|
|
|
Sept. 17, 2020 |
Sept. 15, 2020 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
9,261
-0.2%
13.16
121,913
USD
|
9,261
-0.2%
|
13.16
|
121,913
USD
|
|
|
Sept. 17, 2020 |
Sept. 15, 2020 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
32,336
-0.8%
12.45
402,564
USD
|
32,336
-0.8%
|
12.45
|
402,564
USD
|
|
|
July 22, 2020 |
July 20, 2020 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
12,483
-0.3%
11.94
149,102
USD
|
12,483
-0.3%
|
11.94
|
149,102
USD
|
|
|
July 22, 2020 |
June 29, 2020 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
3,280
-0.1%
11.78
38,628
USD
|
3,280
-0.1%
|
11.78
|
38,628
USD
|
|
|
July 1, 2020 |
June 29, 2020 |
PS
Planned sale
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
3,280
-0.1%
11.78
38,628
USD
|
3,280
-0.1%
|
11.78
|
38,628
USD
|
|
|
Jan. 31, 2020 |
Jan. 29, 2020 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
|
5,500
-9.3%
12.73
69,992
USD
|
5,500
-9.3%
|
12.73
|
69,992
USD
|
|
|
Jan. 27, 2020 |
Jan. 23, 2020 |
S
Sale
|
Lilja Anders
Sr. VP, Technical Development
|
7,568
-100.0%
12.81
96,932
USD
|
7,568
-100.0%
|
12.81
|
96,932
USD
|
|
|
Jan. 27, 2020 |
Jan. 23, 2020 |
S
Sale
|
Lilja Anders
Sr. VP, Technical Development
|
4,075
-100.0%
12.17
49,601
USD
|
4,075
-100.0%
|
12.17
|
49,601
USD
|
|
|
Jan. 21, 2020 |
Jan. 21, 2020 |
S
Sale
|
Orlinger Klaus
Sr. VP, Research
|
6,789
-100.0%
12.02
81,592
USD
|
6,789
-100.0%
|
12.02
|
81,592
USD
|
|
|
Jan. 21, 2020 |
Jan. 16, 2020 |
S
Sale
|
Orlinger Klaus
Sr. VP, Research
|
1,711
-100.0%
11.56
19,781
USD
|
1,711
-100.0%
|
11.56
|
19,781
USD
|
|
|
Jan. 16, 2020 |
Jan. 14, 2020 |
S
Sale
|
Orlinger Klaus
Sr. VP, Research
|
8,500
-100.0%
11.30
96,053
USD
|
8,500
-100.0%
|
11.30
|
96,053
USD
|
|
|
Dec. 23, 2019 |
Dec. 19, 2019 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
10,404
-15.0%
9.93
103,312
USD
|
10,404
-15.0%
|
9.93
|
103,312
USD
|
|
|
Dec. 19, 2019 |
Dec. 17, 2019 |
S
Sale
|
Matushansky Igor
Chief Medical Officer
Officer
|
11,484
-20.9%
7.87
90,379
USD
|
11,484
-20.9%
|
7.87
|
90,379
USD
|
|
|
April 25, 2019 |
April 23, 2019 |
B
Purchase
|
Forbion Capital Fund II Cooperatief U.A.
Major owner
|
53,571
+2.2%
14.00
749,994
USD
|
53,571
+2.2%
|
14.00
|
749,994
USD
|
|
|
April 25, 2019 |
April 23, 2019 |
B
Purchase
|
SOFINNOVA CAPITAL VI FCPR
Major owner
|
357,142
+9.9%
14.00
4,999,988
USD
|
357,142
+9.9%
|
14.00
|
4,999,988
USD
|
|
|
April 23, 2019 |
April 23, 2019 |
B
Purchase
|
BAKER BROS. ADVISORS LP
Former 10% owner
|
820,729
+inf%
14.00
11,490,206
USD
|
820,729
+inf%
|
14.00
|
11,490,206
USD
|
|
|
April 23, 2019 |
April 23, 2019 |
B
Purchase
|
BAKER BROS. ADVISORS LP
Former 10% owner
|
72,128
+inf%
14.00
1,009,792
USD
|
72,128
+inf%
|
14.00
|
1,009,792
USD
|
|
